Aevitas Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.51M Buy
5,752
+12
+0.2% +$3.22K 0.89% 27
2022
Q3
$1.29M Sell
5,740
-114
-2% -$27.6K 0.97% 30
2022
Q2
$1.42M Buy
5,854
+31
+0.5% +$7.6K 0.96% 32
2022
Q1
$1.41M Sell
5,823
-300
-5% -$68.9K 0.86% 36
2021
Q4
$1.38M Buy
6,123
+21
+0.3% +$4.43K 0.82% 35
2021
Q3
$1.3M Sell
6,102
-19
-0.3% -$4.37K 0.83% 32
2021
Q2
$1.49M Buy
6,121
+417
+7% +$103K 0.95% 31
2021
Q1
$1.42M Sell
5,704
-40
-0.7% -$9.54K 0.99% 29
2020
Q4
$1.32M Buy
5,744
+66
+1% +$15.2K 0.97% 28
2020
Q3
$1.44M Buy
5,678
+13
+0.2% +$3.22K 1.19% 24
2020
Q2
$1.34M Buy
5,665
+16
+0.3% +$3.65K 1.23% 23
2020
Q1
$1.15M Sell
5,649
-100
-2% -$21.8K 1.28% 21
2019
Q4
$1.39M Buy
5,749
+31
+0.5% +$6.83K 1.3% 23
2019
Q3
$1.11M Buy
5,718
+313
+6% +$60.1K 1.11% 28
2019
Q2
$996K Buy
5,405
+57
+1% +$10.2K 1% 29
2019
Q1
$1.02M Buy
5,348
+63
+1% +$12K 0.9% 31
2018
Q4
$1.03M Buy
5,285
+12
+0.2% +$2.34K 1.05% 25
2018
Q3
$1.09M Buy
5,273
+119
+2% +$23.5K 0.99% 28
2018
Q2
$951K Buy
5,154
+8
+0.2% +$1.42K 0.93% 33
2018
Q1
$877K Sell
5,146
-106
-2% -$19.5K 0.88% 37
2017
Q4
$913K Buy
+5,252
New +$929K 0.87% 40

Other funds holding AMGN

Aevitas Wealth Management's AMGN Position: Q4 2022 in Review

Aevitas Wealth Management increased its Amgen (AMGN) stake by 0.21% in Q4 2022, buying an estimated $3.22K and bringing the position to 5,752 shares worth $1.51M. The position accounts for 0.89% of the portfolio, ranked #27.

Aevitas Wealth Management first reported a position in AMGN in Q4 2017 and has held it in 21 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Aevitas Wealth Management held 5,752 shares of Amgen worth $1.51M as of Q4 2022.
  • Aevitas Wealth Management bought 12 Amgen shares in Q4 2022, an estimated $3.22K.
  • Amgen made up 0.89% of Aevitas Wealth Management's portfolio in Q4 2022, its #27 holding.
  • Aevitas Wealth Management first reported a position in Amgen in Q4 2017 and has held it in 21 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Aevitas Wealth Management's 13F filing for Q4 2022, filed 24 Jan 2023.